QID 317162

Date Published: 2022-04-26

QID 317162: Cisco Internetwork Operating System (IOS) XE Software Tool Command Language Privilege Escalation Vulnerability (cisco-sa-iosxe-priv-esc-grbtubU)

A vulnerability in the Tool Command Language (Tcl) interpreter of Cisco IOS XE Software
could allow an authenticated, local attacker to escalate from privilege level 15 to root-level privileges.

Affected Products
Cisco devices if they were running a vulnerable release of Cisco IOS XE Software and supported the tclsh command.
Note: Devices are not considered vulnerable if they do not support the command or if the command returns an error.

QID Detection Logic (Authenticated):
The check matches Cisco IOS XE version retrieved via Unix Auth using "show version" command.
QID Detection Logic (Unauthenticated):
The check matches Cisco IOS XE version retrieved via SNMP or TCP/IP Fingerprint or NTP or Telnet.

A successful exploit could allow the attacker to execute arbitrary commands as root. By default, Tcl shell access requires privilege level 15.

CVSS V3 rated as High - 6.7 severity.

CVSS V2 rated as High - 7.2 severity.

Solution

Customers are advised to refer to cisco-sa-iosxe-priv-esc-grbtubU for more information.

Vendor References

cisco-sa-iosxe-priv-esc-grbtubU - tools.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-iosxe-priv-esc-grbtubU

CVEs related to QID 317162

CVE-2022-20676 |

Software Advisories

Advisory ID	Software	Component	Link
cisco-sa-iosxe-priv-esc-grbtubU			tools.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-iosxe-priv-esc-grbtubU

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].